Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments

  • Cendrós, Marc
  • Catalán, Rosa|||0000-0001-7003-2401
  • Torra, Mercè
  • Penadés, Rafael|||0000-0002-1564-3717
  • González-Rodríguez, Alexandre|||0000-0003-1855-8566
  • Brunet, Mercè|||0000-0002-7154-916X
  • Perez Blanco, Josefina|||0000-0002-6489-8871
  • Cullell, Natalia|||0000-0001-5118-1014
  • Serra-Llovich, Alexandre|||0000-0001-8318-851X
  • Hernandez, Marta H.
  • Arranz, María Jesús|||0000-0002-6757-9198
Traditionally, the aetiology of schizophrenia has been attributed to dopaminergic neurotransmission, but more recent information points to the role of glutamate pathways. Glutamatergic involvement in schizophrenia might be extensible to drug response. The aim of the study was to explore whether the variation in glutamate receptors, transporters and metabolism can influence the outcome of drug treatments. A total of 45 polymorphisms in the genes GRIN1, GRIN2A, GRIN2B, GRIN3A, GRIA1, GRIK2, GRM2, GRM3, GRM5, GRM8, SLC1A1, SLC1A3 and GAD1 were genotyped in 258 patients with schizophrenia. Efficacy and side effects were evaluated with the Positive and Negative Symptoms Scale and the UKU scale, respectively, at baseline and after 12 weeks. The analysis revealed associations between outcomes, including response and adverse effects and genetic variants in several genes (GAD1, GRIA1, GRIN2A, GRIN3A, GRIK2, GRM2, GRM5, GRM8 and SLC1A3). An association of rs1864205 in GRIA1 with autonomic side effects bordered statistical significance after correction for multiple comparisons. Our results suggest that genetic variation in glutamatergic pathways can influence the efficacy and safety of antipsychotic drugs.
Repisalud
Publication Artículo científico (JournalArticle)

Genetic Characterization of Rubella Virus Strains Detected in Spain, 1998-2014

  • Martinez Torres, Alex O.
  • Mosquera Gutierrez, Maria del Mar
  • De Ory, Fernando de
  • González-Praetorius, Alejandro
  • Echevarria, Juan Emilio
The National Plan for the Elimination of Rubella was implemented in Spain in 2008 using the logistics of the National Plan for the Elimination of Measles that have been employed since year 2000. Molecular characterization of rubella virus (RUBV) is important for disease surveillance and for monitoring elimination of the disease throughout the world. We describe the first complete series of data regarding the circulation of RUBV genotypes in Spain. The 739-nucleotide fragment designated by the WHO for RUBV genotyping was sequenced in 88 selected cases collected from 1998 to 2014. Five genotypes were identified: 1E, 2B, 1J, 1I, and 1a. Genotype 1E was predominant between 1998 and 2003 but was replaced by genotype 2B, which was detected in sporadic cases in 2004, 2006, 2008, 2012, 2013 and 2014. There was an outbreak of genotype 2B in Algeciras (Andalusia) in 2008. Genotype 1J caused an outbreak in Madrid in 2004/2005 and sporadic cases in 2005 and 2007. Genotype 1I was found to have infected an immune-suppressed patient with neurological symptoms in 2008. Finally, vaccine strain RA 27/3 was detected in three sporadic cases, two of them immune-suppressed and without a recent history of vaccination. This suggests that during these years there were a series of imported sporadic cases and outbreaks, confirming the findings of epidemiological data analysis. The importation sources were generally consistent with our geographic and cultural ties, mainly with Europe (genotypes 1E, 2B, 1I) and Latin America (1J).
Repisalud
Publication Artículo científico (JournalArticle)

Measles virus genotype D4 strains with non-standard length M-F non-coding region circulated during the major outbreaks of 2011-2012 in Spain

  • Gil, Horacio
  • Fernandez-Garcia, Aurora
  • Mosquera Gutierrez, Maria del Mar
  • Hübschen, Judith M
  • Castellanos-Nadal, Ana Maria
  • De Ory, Fernando de
  • Masa-Calles, Josefa
  • Echevarria, Juan Emilio
In recent decades, vaccination has substantially reduced the number of measles cases to levels close to the elimination stage. However, major measles outbreaks occurred in Europe during 2010-2012, after the introduction of the D4-Enfield lineage. We have performed a molecular characterization of 75 measles virus genotype D4 strains from patients infected in Spain between 2004 and 2012 by sequencing the N-450 region and the M-F non-coding region (M-F NCR) in order to identify genetic features of these viruses. The analysis of the N-450 region confirmed that all samples obtained since 2008 belonged to variants or sets of identical sequences of the D4-Enfield lineage, including a new one named MVs/Madrid.ESP/46.10/. Analysis of the M-F NCR showed insertions and deletions associated with previously described, uncommon non-standard genome length measles viruses. This genetic feature was identified in the D4-Enfield lineage viruses, but not in the other D4 viruses that were circulating in Spain before 2008, suggesting that these non-standard length M-F NCR sequences are characteristic of the D4-Enfield lineage. The results of the phylogenetic analysis of Spanish M-F NCRs suggest higher resolution in discriminating strains than did the N-450 analysis. In addition, the results of the analysis of the M-F NCR on the MVs/Madrid.ESP/46.10/ sub-lineage seem to support the potential utility of this region as a tool for epidemiological surveillance complementary to the N-450 region, as previously suggested. Further investigation on this question, as well as the surveillance of new potentially emerging strains with non-standard length M-F NCR are strongly recommended as part of future strategies for measles elimination.
Repisalud
Publication Artículo científico (JournalArticle)

Genomic non-coding regions reveal hidden patterns of mumps virus circulation in Spain, 2005 to 2015

  • Gavilán, Ana M
  • Fernandez-Garcia, Aurora
  • Rueda, Angel
  • Castellanos-Nadal, Ana Maria
  • Masa-Calles, Josefa
  • Lopez-Perea, Noemi
  • Torres-de Mier, Maria de Viarce
  • De Ory, Fernando de
  • Echevarria, Juan Emilio
BackgroundSince mumps vaccination was introduced in 1981 in Spain, the incidence of the disease has dropped significantly. However, cyclic epidemic waves and outbreaks still occur, despite high vaccination coverage. The World Health Organization (WHO) recommends genotyping to trace the pattern of mumps virus (MuV) circulation. Genotype H was predominant in Spain, but was replaced in 2005 by genotype G which has subsequently remained dominant. Of the small hydrophobic protein gene sequences, 78% are identical and belong to the MuVi/ Sheffield.GBR.1.05/[G]-variant. Aim: Our study aimed to investigate whether the circulation of MuV strains in Spain was continuous after the emergence of genotype G in 2005. Method: We obtained 46 samples from Spanish patients infected with MuVi/Sheffield.GBR.1.05/[G] during two epidemic waves and analysed them using new molecular markers based on genomic non-coding regions (NCRs) that discriminate subvariants of this virus strain. Results: Phylogenetic analyses of the nucleoprotein-phosphoprotein and matrix protein-fusion protein NCR indicated strain replacement after a drop in incidence in 2009, which had not been detectable by SH sequencing. Clustering of sequences from patients epidemiologically linked in the same outbreak suggests a potential use for these NCRs in outbreak characterisation. Conclusion: We suggest to consider their use in conjunction with the SH gene in the future WHO recommendations for MuV epidemiological surveillance.
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Publication Artículo de revisión (ReviewArticle)

What are the effects of energy poverty and interventions to ameliorate it on people's health and well-being?: A scoping review with an equity lens

  • Ballesteros-Arjona, Virginia
  • Oliveras, Laura
  • Bolívar Muñoz, Julia
  • Olry de Labry Lima, Antonio
  • Carrere, Juli
  • Martín Ruiz, Eva
  • Peralta, Andrés
  • Cabrera León, Andrés
  • Mateo Rodríguez, Inmaculada
  • Daponte-Codina, Antonio
  • Marí-Dell'Olmo, Marc
Several studies have shown how energy poverty (EP) increases morbidity and mortality, being a growing problem worldwide. We conducted a scoping review to synthesize the state of knowledge on the relationship between energy poverty (EP) and health, analysing the results according to different axes of inequality (gender, age, ethnicity/country of birth, social class, territory). We searched different bibliographic databases (MeSH and free-text terms); Eligibility criteria: 1] studies or interventions related to EP or its different expressions (inadequate temperatures; financial strain, inadequate housing conditions, composite indicators, heating and energy efficiency improvements); 2] health or health risk outcomes; 3] OECD countries; 4] English or Spanish language; 5] published before July 2020. We selected 38 studies out of 2768 (23 observational and 15 interventions). Almost all were quantitative (89.5%) and almost half were conducted in the UK (47.4%). The most studied EP expression was inadequate temperature. Eleven studies disaggregate the analyses by at least one axis of inequality and 21 target a vulnerable group. The studies linked EP to poorer general health, poorer mental health, poorer respiratory health, more and worse controlled chronic conditions, higher mortality, higher use of health services and higher exposure to health risks, with worse results for vulnerable groups across dimensions of inequality. Current scientific evidence should guide structural changes and immediate interventions to ameliorate EP. Future research must take into account the effects of inadequate warm temperatures and social inequalities, especially in the current context of climate and social crisis, the latter being exacerbated by the covid-19 pandemic., Yes
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development of digestive enzymes in common dentex Dentex dentex during early ontogeny

  • Gisbert, Enric
  • Giménez, Gemma
  • Fernández Monzón, Ignacio
  • Kotzamanis, Yannis
  • Estévez, Alicia
7 páginas, 3 figuras., The digestive physiology of common dentex was studied by assessing the activity of different pancreatic (trypsin, chymotrypsin, amylase and lipase), intestinal (alkaline phosphatase, aminopeptidase N, maltase and leuncine-alanine peptidase) and gastric (pepsin) enzymes from hatching until the juvenile stage (50 dph at 19 °C). Enzymes involved in the digestion of protein, lipid and carbohydrate were present in common dentex larvae at hatching and before the onset of exogenous feeding. The specific activity of trypsin and chymotrypsin in newly hatched larvae was higher than that of amylase and lipase, indicating the importance of these enzymes in the cleavage of yolk proteins and hatching, while after hatching, the activity of these serine proteases dramatically decreased, whereas lipase showed the opposite trend. A progressive shift in activity from alkaline to acid proteases was observed during larval development, reflecting that alkaline proteases were not longer the main digestive enzymes involved in protein digestion after the development of gastric glands and onset of acidic digestion. Lipase total activity in common dentex peaked at 35 dph and decreased after weaning. Diet change due to weaning might partially explain the decrease in lipase activity, although this change might be also indicative of a change in the nutritional requirements of this species, since the juveniles prefer diets with high protein levels than those with lower protein and higher lipid content. Regarding intestinal enzymes, leucine-alanine peptidase and alkaline phosphatase and aminopeptidase N were found in newly hatched larvae, while maltase was detected after the onset of exogenous feeding. The achievement of an efficient brush border membrane digestion takes place much earlier (6-12 dph) than in any of the studied species which might reflect the different metabolic profile and rapid growth of this species. © 2008 Elsevier B.V. All rights reserved., Authors would like to express their gratitude to J. Canoura, M. Monllaó and N. Gras for their excellent technical assistance with live prey rearing. Funding was provided to A.E. by the Spanish Ministries of Agriculture Fisheries and Food (Jacumar) and Science and Education (INIA project ACU02-006). The collaboration with Y.K. (HMCR, Greece) was established thanks to the HG2004-0018 grant (MEC, Spain). EG was supported by the Programa Ramón y Cajal (MEC, Spain)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Egg quality variability in common dentex (Dentex dentex, L.): Comparison of different quality indexes

  • Giménez Papiol, G.
  • Estévez, A.
The egg quality of two common dentex captive broodstocks were monitored for two consecutive years during their natural spawning season. Volume of spawned eggs, volume of buoyant eggs, fertilization rate, egg weight, hatching rate and mortality of larvae were recorded. According to the volume of spawned eggs, the ratio of buoyant eggs spawned, the number of spawning days and the fertilization rate pointed to an improvement from Year 1 to Year 2. But data on hatching rate and larval mortality lead to the opposite conclusion., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Effects of dietary arachidonic and eicosapentaenoic acids on common dentex (Dentex dentex Linnaeus 1758) larval performance

  • Giménez Papiol, Gemma
  • Estévez, Alicia
Oily emulsions containing constant levels of total fatty acids (FAs) and varying eicosapentaenoic acid (EPA) and arachidonic acid (ARA) levels were used to enrich rotifers. Common dentex larval survival and growth were compared between groups fed different enriched live prey. Growth, survival rate, and lipid composition of larvae suggest that feeding common dentex in the first 15 days posthatching with 2.5–3% EPA, 6–8% docosahexaenoic acid (DHA), and DHA/EPA ratio of 2.0–2.5 is sufficient to fulfill their EPA requirements. Higher amounts of dietary EPA did not result in any significant improvement in growth or survival. EPA requirement during this period of larval development does not seem to be as critical as other FAs during the first 15 days of common dentex larval development, but it does not exclude its essentiality later in development. In the case of ARA, nutritional requirements are low compared to other marine finfish species, with the upper limit of this essential FA being around 2% of total FAs provided in the live prey composition., info:eu-repo/semantics/acceptedVersion
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Energy poverty, its intensity and health in vulnerable populations in a Southern European city, Pobreza energética, su intensidad y salud en población vulnerable en una ciudad del sur de Europa

  • Carrere, Juli|||0000-0001-5865-753X
  • Peralta Chiriboga, Alejandro Andrés|||0000-0002-7617-108X
  • Oliveras, Laura|||0000-0003-0033-7829
  • López Medina, María José|||0000-0003-4402-2239
  • Marí-Dell'Olmo, Marc|||0000-0003-4345-4988
  • Benach, Joan|||0000-0003-2285-742X
  • Novoa, Ana M.|||0000-0002-5068-3503
Objective: To describe and compare the health status between vulnerable population participating in a program to tackle energy poverty (Energía, la justa) and the non-energy poor Barcelona (Spain) population and to analyse among participants the effect of energy poverty intensity on health. Method: Cross-sectional study based on data from program participants obtained before the intervention. Participants (1799 women and 671 men) were compared to non-energy poor population of Barcelona (1393 women and 1215 men) sampled from the Barcelona Public Health Survey (2016). Standardized prevalence and prevalence ratios of self-perceived poor health, asthma, chronic bronchitis, and depression and/or anxiety were estimated, and among participants the association between health status and energy poverty intensity was estimated with multivariate models. Results: The probability of poor self-perceived physical and mental health ranged from 2.2 to 5.3 times greater in the program participants than non-energy poor Barcelona population. Among program participants, those most affected were found to be the most likely to report poor health outcomes, regardless of other sociodemographic factors. Conclusions: The prevalence of poor physical and mental health was considerably higher among women and men participating in the programme compared to the non-energy poor population and was even worse among those who were more severely affected. Public policies that tackle energy poverty and its consequences are urgently needed in Spain., Objetivo: Describir y comparar el estado de salud entre la población vulnerable que participa en un programa de lucha contra la pobreza energética (Energía, la justa) y la población sin pobreza energética de Barcelona (España), y analizar entre las personas participantes el efecto de la intensidad de la pobreza energética en la salud. Método: Estudio transversal basado en datos de los/las participantes en el programa obtenidos antes de la intervención. Se compararon los/las participantes (1799 mujeres y 671 hombres) con población sin pobreza energética de Barcelona (1393 mujeres y 1215 hombres) seleccionada de la Encuesta de Salud Pública de Barcelona (2016). Se estimaron la prevalencia estandarizada y las razones de prevalencia de mala salud, asma, bronquitis crónica y depresión o ansiedad autopercibida. Entre los/las participantes se estimó la asociación entre el estado de salud y la intensidad de la pobreza energética con modelos multivariantes. Resultados: Los/las participantes presentaron entre 2,2 y 5,3 veces peores resultados en salud que la población sin pobreza energética. Entre los/las participantes se encontró que las personas más afectadas eran las que tenían más probabilidades de reportar peores resultados de salud, independientemente de otros factores sociodemográficos. Conclusiones: La prevalencia de mala salud física y mental era considerablemente mayor en las mujeres y los hombres que participaron en el programa en comparación con la población sin pobreza energética, y era aún peor entre los/las más severamente afectados. En España se necesitan con urgencia políticas públicas que aborden la pobreza energética y sus consecuencias.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The association of energy poverty with health and wellbeing in children in a mediterranean city

  • Oliveras, Laura|||0000-0003-0033-7829
  • Borrell i Thió, Carme|||0000-0002-1170-2505
  • González-Pijuan, Irene|||0000-0002-9870-1360
  • Gotsens, Mercè|||0000-0003-2952-2024
  • López Medina, María José|||0000-0003-4402-2239
  • Palència, Laia|||0000-0002-3726-9893
  • Artazcoz, Lucía|||0000-0002-6300-5111
  • Marí-Dell'Olmo, Marc|||0000-0003-4345-4988
Children have been identified as being particularly vulnerable to energy poverty (EP), but little empirical research has addressed the effect of EP on children's health and wellbeing, especially in southern Europe. In this work we aimed to provide an in-depth description of the distribution of EP by sociodemographic, socioeconomic and housing characteristics, as well as to analyse the association between EP and health and wellbeing in children in Barcelona. We performed a cross-sectional study using data from the Barcelona Health Survey for 2016 (n = 481 children under 15 years). We analysed the association between EP and health outcomes through prevalence differences and prevalence ratios (PR) and their 95% confidence interval (CI), using Poisson regression models with robust variance. In Barcelona, 10.6% of children were living in EP and large inequalities were found by sociodemographic, socioeconomic and housing characteristics. EP was strongly associated with poor health in children (PR (95% CI): 7.70 (2.86, 20.72)). Living in EP was also associated with poor mental health (PR (95% CI): 2.46 (1.21, 4.99)) and with more cases of asthma (PR (95% CI): 4.19 (1.47, 11.90)) and overweight (PR (95% CI): 1.50 (1.05, 2.15)) in children. It is urgent to develop specific measures to avoid such serious and unfair health effects on children.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Energy poverty and health, Trends in the European Union before and during the economic crisis, 2007-2016

  • Oliveras, Laura|||0000-0003-0033-7829
  • Peralta, A.
  • Palència, Laia|||0000-0002-3726-9893
  • Gotsens, Mercè|||0000-0003-2952-2024
  • López Medina, María José|||0000-0003-4402-2239
  • Artazcoz, Lucía|||0000-0002-6300-5111
  • Borrell i Thió, Carme|||0000-0002-1170-2505
  • Marí-Dell'Olmo, Marc|||0000-0003-4345-4988
The aim of this study is to analyse the time trends in the European Union (EU) before and during the economic crisis in 1) the energy poverty (EP) prevalence; 2) the association between EP and health and 3) the impact of EP on health. We analyse trends among women and men in two EU macro regions, defined by a novel index of structural vulnerability to EP. The study shows how EP and its impact on health worsened during the economic crisis and identifies groups at higher risk such as women and people living in Mediterranean and Eastern European countries, which have been found to be countries with higher structural vulnerability to EP.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Geographical inequalities in energy poverty in a Mediterranean city, Using small-area Bayesian spatial models

  • Marí-Dell'Olmo, Marc|||0000-0003-4345-4988
  • Oliveras, Laura|||0000-0003-0033-7829
  • Vergara-Hernández, Carlos|||0000-0002-7263-856X
  • Artazcoz, Lucía|||0000-0002-6300-5111
  • Borrell i Thió, Carme|||0000-0002-1170-2505
  • Gotsens, Mercè|||0000-0003-2952-2024
  • Palència, Laia|||0000-0002-3726-9893
  • López Medina, María José|||0000-0003-4402-2239
  • Martinez-Beneito, Miguel A.|||0000-0001-8406-8050
Energy poverty (EP) is becoming an increasingly important problem in the urban contexts of southern Europe. In Barcelona, EP indicators are higher than those of the European Union and are strongly associated with poor health status and high use of health services and medication, becoming a major public health problem. EP is unevenly distributed in the population of Barcelona, according to axes of social stratification. However, its geographic distribution at the small-area level remains unknown because it cannot be directly estimated with the available information sources and commonly used methods. Therefore, the aim of this study was to analyze geographical inequalities in EP in Barcelona by estimating reliable small-area EP indicators and a composite indicator (index). We used a novel method that allowed us to obtain 6 EP indicators for the 73 Barcelona neighborhoods and an EP index from a principal component analysis of these indicators. We found major geographical inequalities in the distribution of EP in Barcelona. Many neighborhoods had significantly higher EP than the city average, and these areas made up 3 well-defined spatial clusters. Therefore, the estimated small-area indicators and index allowed identification of the most affected neighborhoods. These results indicate the need to prioritize these areas for local interventions to alleviate EP, and could also be used for policy making.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The association of energy poverty with health, health care utilisation and medication use in southern Europe

  • Oliveras, Laura|||0000-0003-0033-7829
  • Artazcoz, Lucía|||0000-0002-6300-5111
  • Borrell i Thió, Carme|||0000-0002-1170-2505
  • Palència, Laia|||0000-0002-3726-9893
  • López Medina, María José|||0000-0003-4402-2239
  • Gotsens, Mercè|||0000-0003-2952-2024
  • Peralta, A.
  • Marí-Dell'Olmo, Marc|||0000-0003-4345-4988
Energy poverty (EP) is defined as the inability of a household to secure a socially and materially required level of energy services in the home. The main objective of this study was to analyse the association between EP and distinct indicators of health status, health services utilisation and medication use in southern Europe, using the city of Barcelona as a case study. We conducted a cross-sectional study using the data of the Barcelona Health Survey for 2016 (n = 3519, 53.3% women). We calculated EP percentages according to age, country of birth and social class. We analysed the association between EP and 26 health-related indicators through prevalence ratios (PR), and quantified the impact of EP on health at the population level by calculating the percentage of population attributable risk (PAR%). In Barcelona, 13.3% of women and 11.3% of men experienced EP. The most frequently affected groups were people born in low- and middle-income countries, those from more disadvantaged social classes, and women aged 65 years and older. We found a strong association between EP and worse health status, as well as higher use of health services and medication. For example, compared with women without EP, those with EP reported poor mental health 1.9 (95% CI: 1.6-2.4) times more frequently. Compared with men without EP, those with EP reported poor mental health 2.1 (95% CI: 1.6-2.8) times more frequently. The combination of high EP prevalence and the strong association between EP and negative health outcomes resulted in high PAR%, indicating the striking impact of EP on health and health services at the population level. EP is an important public health problem in southern European urban contexts that should be included in policy priorities in order to address its structural causes and minimise its unfair and avoidable health effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments

  • Arranz, María Jesús|||0000-0002-6757-9198
  • Gonzalez-Rodriguez, Alex
  • Perez Blanco, Josefina|||0000-0002-6489-8871
  • Penadés, Rafael|||0000-0002-1564-3717
  • Gutierrez, Blanca
  • Ibañez, Laura
  • Arias, Barbara|||0000-0001-9181-2132
  • Brunet, Mercè|||0000-0002-7154-916X
  • Cervilla, Jorge|||0000-0001-6891-1992
  • Salazar, Juliana|||0000-0002-3581-4499
  • Catalán, Rosa|||0000-0001-7003-2401
Antipsychotic drugs fail to achieve adequate response in 30-50% of treated patients and about 50% of them develop severe and lasting side effects. Treatment failure results in poorer prognosis with devastating repercussions for the patients, carers and broader society. Our study evaluated the clinical benefits of a pharmacogenetic intervention for the personalisation of antipsychotic treatment. Pharmacogenetic information in key CYP polymorphisms was used to adjust clinical doses in a group of patients who started or switched treatment with antipsychotic drugs (PharmG+, N = 123), and their results were compared with those of a group of patients treated following existing clinical guides (PharmG-, N = 167). There was no evidence of significant differences in side effects between the two arms. Although patients who had their antipsychotic dose adjusted according to CYPs polymorphisms (PharmG+) had a bigger reduction in side effects than those treated as usual (PharmG-), the difference was not statistically significant (p.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reporting Items for Updated Clinical Guidelines, Checklist for the Reporting of Updated Guidelines (CheckUp)

  • Vernooij, Robin W. M.|||0000-0001-5734-4566
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Brouwers, Melissa|||0000-0002-9699-0269
  • Martínez García, Laura|||0000-0003-0126-8706
Scientific knowledge is in constant development. Consequently, regular review to assure the trustworthiness of clinical guidelines is required. However, there is still a lack of preferred reporting items of the updating process in updated clinical guidelines. The present article describes the development process of the Checklist for the Reporting of Updated Guidelines (CheckUp). We developed an initial list of items based on an overview of research evidence on clinical guideline updating, the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument, and the advice of the CheckUp panel (n = 33 professionals). A multistep process was used to refine this list, including an assessment of ten existing updated clinical guidelines, interviews with key informants (response rate: 54.2%; 13/24), a three-round Delphi consensus survey with the CheckUp panel (33 participants), and an external review with clinical guideline methodologists (response rate: 90%; 53/59) and users (response rate: 55.6%; 10/18). CheckUp includes 16 items that address (1) the presentation of an updated guideline, (2) editorial independence, and (3) the methodology of the updating process. In this article, we present the methodology to develop CheckUp and include as a supplementary file an explanation and elaboration document. CheckUp can be used to evaluate the completeness of reporting in updated guidelines and as a tool to inform guideline developers about reporting requirements. Editors may request its completion from guideline authors when submitting updated guidelines for publication. Adherence to CheckUp will likely enhance the comprehensiveness and transparency of clinical guideline updating for the benefit of patients and the public, health care professionals, and other relevant stakeholders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development and use of a content search strategy for retrieving studies on patients' views and preferences

  • Selva, Anna|||0000-0002-2754-3158
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Zhang, Yuan
  • Pardo-Hernandez, Hector|||0000-0003-3714-0309
  • Haynes, R. Brian
  • Martínez García, Laura|||0000-0003-0126-8706
  • Navarro, Tamara
  • Schünemann, Holger|||0000-0003-3211-8479
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Identifying scientific literature addressing patients' views and preferences is complex due to the wide range of studies that can be informative and the poor indexing of this evidence. Given the lack of guidance we developed a search strategy to retrieve this type of evidence. We assembled an initial list of terms from several sources, including the revision of the terms and indexing of topic-related studies and, methods research literature, and other relevant projects and systematic reviews. We used the relative recall approach, evaluating the capacity of the designed search strategy for retrieving studies included in relevant systematic reviews for the topic. We implemented in practice the final version of the search strategy for conducting systematic reviews and guidelines, and calculated search's precision and the number of references needed to read (NNR). Results: We assembled an initial version of the search strategy, which had a relative recall of 87.4% (yield of 132/out of 151 studies). We then added some additional terms from the studies not initially identified, and re-tested this improved version against the studies included in a new set of systematic reviews, reaching a relative recall of 85.8% (151/out of 176 studies, 95% CI 79.9 to 90.2). This final version of the strategy includes two sets of terms related with two domains: "Patient Preferences and Decision Making" and "Health State Utilities Values". When we used the search strategy for the development of systematic reviews and clinical guidelines we obtained low precision values (ranging from 2% to 5%), and the NNR from 20 to 50. This search strategy fills an important research gap in this field. It will help systematic reviewers, clinical guideline developers, and policy-makers to retrieve published research on patients' views and preferences. In turn, this will facilitate the inclusion of this critical aspect when formulating heath care decisions, including recommendations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Continuous surveillance of a pregnancy clinical guideline, An early experience

  • Martínez García, Laura|||0000-0003-0126-8706
  • Pardo-Hernandez, Hector|||0000-0003-3714-0309
  • Sanabria, Andrea Juliana
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Aceituno-Velasco, Longinos
  • Araya, Ignacio
  • Muñoz, Emilia Bailon
  • Díaz del Campo, Petra
  • Etxeandia-Ikobaltzeta, Itziar|||0000-0001-6606-649X
  • Fillol Crespo, Manuel
  • Fuertes Luis, Lucía
  • García Álvarez, Elvira
  • García Carrascosa, Laura
  • Gómez Gómez, Natalia
  • Herrera Crerizo, Blanca
  • Landa Goñi, Jacinta
  • López, Dario
  • Louro González, Arturo|||0000-0002-8334-9210
  • Martínez-Romero, María Dolores
  • Martín-López, Juliana Ester
  • Montejo Ráez, Adoración
  • Osorio, Dimelza|||0000-0001-6166-647X
  • Roman Romera, Isabel
  • Salcedo-Fernandez, Flavia
  • Selva, Anna|||0000-0002-2754-3158
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Strivens, Helen
  • Torrejón Cardoso, Rafael|||0000-0001-8472-8290
  • Trujillo Martín, Mar
  • Vernooij, Robin W. M.|||0000-0001-5734-4566
To date there is no consensus about the optimal strategy for keeping clinical guidelines (CGs) up-to-date. The aims of this study were (1) to develop a continuous surveillance and updating strategy for CGs and (2) to test the strategy in a specific CG. The main steps were as follows: (1) recruiting members for the CG Updating Working Group, (2) mapping the CG, (3) identifying new evidence from the CG Updating Working Group, (4) designing and running restricted literature searches, (5) reviewing drugs and medical devices alerts, (6) screening and assessing the new evidence, (7) reviewing and, if necessary, modifying clinical questions and recommendations, and (8) updating the CG document. The Pregnancy CG Updating Working Group consisted of 29 members, including clinicians, patients and caregivers, and clinical guideline methodology experts. We selected 69 clinical questions (123 recommendations) from the "Assistance during pregnancy" section. For the first update cycle (32-month duration), 9710 references were identified. Of these, 318 were pertinent, 289 were relevant, and 55 were classified as potential key references. For the second and third update cycles (6-month duration each), 2160 and 2010 references were retrieved, respectively. The continuous surveillance and updating strategy has not yet been completely implemented. Further resources are needed in updating the CG field, both for implementing updating strategies and for developing methodological research.
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Egg quality variability in common dentex (Dentex dentex, L.): Comparison of different quality indexes

  • Giménez Papiol, G.
  • Estévez, A.
The egg quality of two common dentex captive broodstocks were monitored for two consecutive years during their natural spawning season. Volume of spawned eggs, volume of buoyant eggs, fertilization rate, egg weight, hatching rate and mortality of larvae were recorded. According to the volume of spawned eggs, the ratio of buoyant eggs spawned, the number of spawning days and the fertilization rate pointed to an improvement from Year 1 to Year 2. But data on hatching rate and larval mortality lead to the opposite conclusion., info:eu-repo/semantics/acceptedVersion
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Effects of dietary arachidonic and eicosapentaenoic acids on common dentex (Dentex dentex Linnaeus 1758) larval performance

  • Giménez Papiol, Gemma
  • Estévez, Alicia
Oily emulsions containing constant levels of total fatty acids (FAs) and varying eicosapentaenoic acid (EPA) and arachidonic acid (ARA) levels were used to enrich rotifers. Common dentex larval survival and growth were compared between groups fed different enriched live prey. Growth, survival rate, and lipid composition of larvae suggest that feeding common dentex in the first 15 days posthatching with 2.5–3% EPA, 6–8% docosahexaenoic acid (DHA), and DHA/EPA ratio of 2.0–2.5 is sufficient to fulfill their EPA requirements. Higher amounts of dietary EPA did not result in any significant improvement in growth or survival. EPA requirement during this period of larval development does not seem to be as critical as other FAs during the first 15 days of common dentex larval development, but it does not exclude its essentiality later in development. In the case of ARA, nutritional requirements are low compared to other marine finfish species, with the upper limit of this essential FA being around 2% of total FAs provided in the live prey composition., info:eu-repo/semantics/acceptedVersion